Precision Biosciences Inc (DTIL) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 12, 2026.
- Filings shown
- 18
- Open-market buys
- 3
- Open-market sells
- 1
- Buys, 10b5-1 box not checked
- 3 of 3
Counts cover the 18 most recent Form 4 filings Tradune holds for DTIL (filed May 22 – Nov 12, 2026); the score below covers only the trailing 90 days (3 buys, 1 sell). SEC EDGAR Form 4 filings for DTIL last checked Nov 21, 2026, 09:00 UTC; the latest DTIL filing Tradune holds was filed Nov 12, 2026. This is not guaranteed to be the complete record — see DTIL's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 4 filings Tradune holds for DTIL filed Sep 29 – Nov 12, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
1 open-market sale by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 1 sale· 2,821 sh
- checkbox disclosed
- On filings with the box not checked
- 0 sales· 0 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Dario ScimecaChief Legal Officer | 0 | 1 | — | 2,821 | −$27,505 |
| Geno J. GermanoDirector | 1 | 0 | 2,609 | — | +$16,385 |
| Melinda BrownDirector | 1 | 0 | 1,135 | — | +$7,116 |
| Stanley FrankelDirector | 1 | 0 | 1,000 | — | +$6,000 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
100/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
Weekly signal history
DTIL appeared in 1 archived weekly edition as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.
- Week of Nov 17, 2026 3 insiders buying · $1,996 net
An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at DTIL
Insiders reported 3 open-market purchases of DTIL between May 22, 2026 and Nov 12, 2026, across 3 distinct buyers. The most recent purchase was reported by Stanley Frankel (Director) on Sep 28, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 2,821 | $9.75 | 56,782 | −4.7% | Nov 10, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 1,000 | $6.00 | 41,478 | +2.5% | Sep 28, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 1,135 | $6.27 | 45,481 | +2.6% | Sep 25, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,609 | $6.28 | 47,492 | +5.8% | Sep 25, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 20,979 | — | — | — | Jun 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 20,979 | — | — | — | Jun 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 20,979 | — | — | — | Jun 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 20,979 | — | — | — | Jun 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 20,979 | — | — | — | Jun 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 57,389 | — | — | — | Jun 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 107,604 | — | — | — | Jun 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 193,688 | — | — | — | Jun 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units | 573,888 | — | — | — | Jun 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Restricted Stock Units | 21,000 | — | — | — | May 20, 2026 |
| Option exercise | 21,000 | — | 49,137 | +75% | May 20, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 21,000 | — | 40,478 | +108% | May 20, 2026 |
| Option exercise Restricted Stock Units | 21,000 | — | — | — | May 20, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Restricted Stock Units | 21,000 | — | — | — | May 20, 2026 |
| Option exercise | 21,000 | — | 44,346 | +90% | May 20, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 21,000 | — | 35,028 | +150% | May 20, 2026 |
| Option exercise Restricted Stock Units | 21,000 | — | — | — | May 20, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise Restricted Stock Units | 21,000 | — | — | — | May 20, 2026 |
| Option exercise | 21,000 | — | 44,883 | +88% | May 20, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to DTIL's (Nov 12, 2026).
Frequently asked about DTIL insider activity
How many insiders bought DTIL stock in these Form 4 filings?
3 distinct insiders at Precision Biosciences Inc reported 3 open-market purchases (Form 4 code P) of DTIL shares between May 22, 2026 and Nov 12, 2026, the most recent filed by Stanley Frankel (Director) on Sep 28, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for DTIL?
The most recent Form 4 on this page was filed by Dario Scimeca (Chief Legal Officer) on Nov 12, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market DTIL insider sale shown?
The largest open-market sale among the filings shown was 2,821 DTIL shares at $9.75 (about $27,505) by Dario Scimeca (Chief Legal Officer) on Nov 10, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.
Do the recent DTIL insider purchases have the Form 4 10b5-1 box checked?
No. All 3 DTIL open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Stanley Frankel (Director) on Sep 28, 2026, 1,000 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for DTIL — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.